EMA gives Myrtelle’s Canavan disease gene therapy candidate OD designation
Myrtelle Inc., a clinical stage gene therapy company, has announced that the European Medicines Agency…
December 15, 2022 - 3 minutes
Myrtelle Inc., a clinical stage gene therapy company, has announced that the European Medicines Agency…